Regulacje i polityka gospodarcza · 26.12.2023

Endocrine Disruptor Screening Program (EDSP); Near-Term Strategies for Implementation; Notice of Availability and Request for Comment; Extension of Comment Period; Correction

In the Federal Register of December 14, 2023, EPA announced the extension of the comment period established in a document that published in the Federal Register of October 27, 2023 that announced the availability of and solicited comment on near-term strategies to help the Agency meet its obligations and commitments under the Federal Food, Drug, and Cosmetic Act (FFDCA), which requires, that EPA screen for and protect against endocrine disrupting effects in humans. This document corrects the extended comment period date that published in the Federal Register of December 14, 2023, which inadvertently included the incorrect year.